Daniel Spratt, MD

Daniel Spratt, MD, University Hospitals Seidman Cancer Center

Articles by Daniel Spratt, MD

Daniel Spratt, MDLocalized | April 17, 2024
Dr. Spratt ponders the evolving integration of RT with systemic treatments, challenges in counseling patients, and more.
Read More
Daniel Spratt, MDLocalized | April 5, 2024
Dr. Spratt reviews the safety and efficacy of relugolix plus RT in patients with localized or advanced prostate cancer.